Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Antares Pharma	Intersect ENT	Invo Bioscience	OraSure Technologies	Vapotherm
Symbol	NASDAQ:ATRS	NASDAQ:XENT	OTCMKTS:IVOB	NASDAQ:OSUR	NYSE:VAPO
Price Information
Current Price	$4.00	$17.66	$0.22	$9.51	$18.01
52 Week Range	Buy	Hold	N/A	Buy	Buy
MarketRank™
Overall Score	1.8	1.7	0.5	1.7	1.5
Analysis Score	3.5	3.2	0.0	3.4	3.5
Community Score	2.8	2.8	2.6	2.8	2.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	1.7	0.0	1.7	1.7
Earnings & Valuation Score	1.9	0.6	0.0	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Hold	N/A	Buy	Buy
Consensus Price Target	$5.75	$25.00	N/A	$17.60	$43.00
% Upside from Price Target	43.75% upside	41.56% upside	N/A	85.07% upside	138.76% upside
Trade Information
Market Cap	$675.19 million	$585.27 million	$619.66 million	$684.34 million	$466.68 million
Beta	1.44	1.34	-0.81	0.04	-1.5
Average Volume	1,142,139	204,562	43,036	1,071,912	341,307
Sales & Book Value
Annual Revenue	$123.86 million	$109.14 million	$490,000.00	$154.60 million	$48.10 million
Price / Sales	5.45	5.36	70.79	4.43	9.70
Cashflow	N/A	N/A	N/A	$0.19 per share	N/A
Price / Cash	N/A	N/A	N/A	50.78	N/A
Book Value	$0.33 per share	$3.75 per share	($0.02) per share	$4.98 per share	$2.55 per share
Price / Book	12.12	4.71	-11.00	1.91	7.06
Profitability
Net Income	$-2,030,000.00	$-42,990,000.00	$-3,080,000.00	$16.66 million	$-51,060,000.00
EPS	($0.01)	($1.37)	N/A	$0.13	($2.74)
Trailing P/E Ratio	66.68	N/A	N/A	N/A	N/A
Forward P/E Ratio	16.67	N/A	∞	10.57	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	6.64%	-71.96%	-166.95%	-9.05%	-47.80%
Return on Equity (ROE)	16.48%	-55.81%	N/A	-3.51%	-51.59%
Return on Assets (ROA)	6.69%	-40.23%	-85.23%	-3.13%	-29.83%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.53%	0.72%	N/A	N/A	0.33%
Current Ratio	2.47%	11.28%	1.05%	8.14%	5.96%
Quick Ratio	2.08%	10.29%	1.02%	7.32%	5.13%
Ownership Information
Institutional Ownership Percentage	39.92%	84.32%	N/A	98.13%	70.35%
Insider Ownership Percentage	5.90%	3.50%	20.64%	1.70%	34.40%
Miscellaneous
Employees	185	406	2	570	397
Shares Outstanding	168.80 million	33.14 million	157.67 million	71.96 million	25.91 million
Next Earnings Date	8/5/2021 (Estimated)	8/3/2021 (Estimated)	N/A	8/4/2021 (Estimated)	8/3/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Optionable	Not Optionable

Source	Headline
	Array Stock Could Rise in the Long Run Despite Near-Term Uncertainty, Says JP Morgan - Report Door reportdoor.com - May 15 at 9:18 AM
	Heliox Market 2021-2026 Global Analysis : BOC Healthcare, Air Liquide Healthcare, Praxair Technology, HycompUSA, VAPOTHERM – Test & Measurement - Test & Measurement testmeasurement.com.au - May 14 at 1:22 PM
	Inflation Angst Sees Korean, Thai Bonds Looking Most Vulnerable - Report Door reportdoor.com - May 14 at 7:51 AM
	High-flow Nasal Cannula Market to Witness Rapid Growth by 2027 \| Vapotherm, Smiths Medical, ResMed – Test & Measurement - Test & Measurement testmeasurement.com.au - May 13 at 1:26 PM
	Ignore the Red Herring, Moderna Stock Is a 'Buy,' Says Oppenheimer - Report Door reportdoor.com - May 13 at 8:26 AM
	Musk Sends Bitcoin Tumbling With Shock U-Turn on Payments - Report Door reportdoor.com - May 13 at 8:26 AM
	Alibaba Targets 30% Revenue Growth After First Loss Since 2012 - Report Door reportdoor.com - May 13 at 8:26 AM
	S&P 500 Price Forecast – Stock Markets Crater Again - Report Door reportdoor.com - May 13 at 8:26 AM
	Ignore the Red Herring, Moderna Stock Is a 'Buy,' Says Oppenheimer – The Madison Leader Gazette - The Madison Leader Gazette wmleader.com - May 13 at 1:19 AM
	American Airlines to resume non-stop service on two flights hit by fuel shortage - Yahoo Finance finance.yahoo.com - May 13 at 1:19 AM
	Gold Price Prediction – Prices Decline on Stronger Inflation Figures as the Dollar Rises - Report Door reportdoor.com - May 13 at 1:19 AM
	Why Costco is secretly a winner from Colonial pipeline shutdown fueled gas lines – The Madison Leader Gazette - The Madison Leader Gazette wmleader.com - May 12 at 8:19 PM
	3 Stocks That Are Flirting With a Bottom; Analysts Say ‘Buy’ - Yahoo Finance finance.yahoo.com - May 12 at 3:18 PM
	Vapotherm (NYSE:VAPO) Releases FY 2021 Earnings Guidance americanbankingnews.com - May 12 at 9:56 AM
	Market Opportunities for High Flow Oxygen Cannula Industry by Fisher & Paykel Healthcare, Vapotherm, ResMed, Teleflex, Salter Labs, Flexicare, and more \| Affluence – Clark County Blog - Clark County Blog clarkcountyblog.com - May 10 at 9:17 PM
	Head to Head Comparison: Ophectra Real Estate and Investments (OTCMKTS:MTTCF) versus Vapotherm (NYSE:VAPO) americanbankingnews.com - May 10 at 3:47 PM
	Piper Sandler Weighs in on Vapotherm, Inc.'s Q3 2021 Earnings (NYSE:VAPO) americanbankingnews.com - May 10 at 2:50 AM
	Q2 2021 Earnings Forecast for Vapotherm, Inc. (NYSE:VAPO) Issued By William Blair americanbankingnews.com - May 10 at 1:14 AM
	Vapotherm, Inc. (VAPO) CEO Joe Army on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - May 9 at 1:21 AM
	The Vapotherm, Inc. (NYSE:VAPO) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Nasdaq nasdaq.com - May 8 at 3:17 PM
	Vapotherm Reports First Quarter 2021 Financial Results - Business Wire businesswire.com - May 7 at 9:26 AM
	Vapotherm: Q1 Earnings Snapshot - Albany Times Union timesunion.com - May 6 at 11:25 PM
	Is Vapotherm Inc (VAPO) Stock a Smart Investment Thursday? - InvestorsObserver investorsobserver.com - May 6 at 6:24 PM
	Vapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1 2021 Financials - Market Globalist marketglobalist.com - May 6 at 1:24 PM
	Vapotherm to Participate in the Bank of America Securities 2021 Health Care Conference - Yahoo Finance finance.yahoo.com - May 6 at 1:24 PM

Date	Company	Brokerage	Action
5/10/2021	Antares Pharma	HC Wainwright	Boost Price Target
10/1/2020	Antares Pharma	Raymond James	Reiterated Rating
6/21/2020	Antares Pharma	Piper Sandler	Reiterated Rating
6/21/2020	Antares Pharma	LADENBURG THALM/SH SH	Reiterated Rating
2/25/2019	Antares Pharma	Cowen	Initiated Coverage
11/6/2018	Antares Pharma	Jefferies Financial Group	Boost Price Target
8/17/2018	Antares Pharma	Piper Jaffray Companies	Reiterated Rating
5/11/2021	Intersect ENT	SVB Leerink	Lower Price Target
1/11/2021	Intersect ENT	Canaccord Genuity	Upgrade
11/19/2020	Intersect ENT	BTIG Research	Upgrade
10/8/2020	Intersect ENT	JPMorgan Chase & Co.	Downgrade
8/7/2020	Intersect ENT	Guggenheim	Upgrade
8/4/2020	Intersect ENT	Oppenheimer	Reiterated Rating
4/15/2020	Intersect ENT	Bank of America	Downgrade
5/6/2021	OraSure Technologies	Lake Street Capital	Lower Price Target
3/2/2021	OraSure Technologies	Citigroup	Lower Price Target
8/21/2020	OraSure Technologies	Evercore ISI	Initiated Coverage
4/21/2020	OraSure Technologies	Stephens	Initiated Coverage
3/5/2020	Vapotherm	William Blair	Reiterated Rating

(Data available from 5/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources